Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies

We studied human immunodeficiency virus type 1 (HIV-1) chimeric viruses altering in their gp120 V1V2 and V3 envelope regions to better map which genetic alterations are associated with specific virus phenotypes associated with HIV-1 disease progression. The V1V2 and V3 regions studied were based on...

Description complète

Détails bibliographiques

Publié dans:	J Virol
Auteurs principaux:	Nabatov, Alexey A., Pollakis, Georgios, Linnemann, Thomas, Kliphius, Aletta, Chalaby, Moustapha I. M., Paxton, William A.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2004
Sujets:	Pathogenesis and Immunity
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303404/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14671134/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.1.524-530.2004
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!